Difficulty: Medium
Average Score: 74%
Practice
Which of the following cholinesterase inhibitors is said to produce more severe muscarinic side effects
Correct answer
B
Rationale
In this question, the correct answer is B) Neostigmine. Neostigmine is known to produce more severe muscarinic side effects compared to the other cholinesterase inhibitors listed.
Neostigmine is a quaternary ammonium compound that acts as a reversible acetylcholinesterase inhibitor. It increases the concentration of acetylcholine at the neuromuscular junction, leading to increased stimulation of both muscarinic and nicotinic receptors. This excess stimulation of muscarinic receptors can result in side effects such as bradycardia, bronchoconstriction, excessive salivation, gastrointestinal disturbances, and sweating.
Pyridostigmine and Ambenonium are also cholinesterase inhibitors, but they are less likely to cause severe muscarinic side effects compared to neostigmine. Pyridostigmine is commonly used in myasthenia gravis, while Ambenonium is less frequently used due to its longer duration of action.
It is important for healthcare professionals, especially those prescribing or administering these medications, to understand the differences in side effect profiles of cholinesterase inhibitors to ensure safe and effective patient care. Understanding these nuances can help in making informed decisions regarding drug selection and management of potential adverse effects.
Neostigmine is a quaternary ammonium compound that acts as a reversible acetylcholinesterase inhibitor. It increases the concentration of acetylcholine at the neuromuscular junction, leading to increased stimulation of both muscarinic and nicotinic receptors. This excess stimulation of muscarinic receptors can result in side effects such as bradycardia, bronchoconstriction, excessive salivation, gastrointestinal disturbances, and sweating.
Pyridostigmine and Ambenonium are also cholinesterase inhibitors, but they are less likely to cause severe muscarinic side effects compared to neostigmine. Pyridostigmine is commonly used in myasthenia gravis, while Ambenonium is less frequently used due to its longer duration of action.
It is important for healthcare professionals, especially those prescribing or administering these medications, to understand the differences in side effect profiles of cholinesterase inhibitors to ensure safe and effective patient care. Understanding these nuances can help in making informed decisions regarding drug selection and management of potential adverse effects.